Beat In-Albon
Net worth: 45 689 $ as of 31/08/2026
Net worth: 45 689 $ as of 31/08/2026
Beat In-Albon currently works at Hans Kalbermatten Thermalbad AG, as Chairman from 2021, Lonza Arena AG, as Vice Chairman from 2020, PolyPeptide Laboratories Holding (PPL) AB, as Independent Director, Deccan Fine Chemicals (India) Pvt Ltd., as Non-Executive Director from 2019, and PolyPeptide Group AG, as Independent Non-Executive Director from 2021.
Dr. In-Albon also formerly worked at Escientia Switzerland AG, as Chairman from 2020 to 2021, Evolva Holding SA, as Vice Chairman from 2023 to 2025, Siegfried Holding AG, as Non-Executive Director from 2011 to 2012, Siegfried AG, as Director from 2009 to 2012, Lonza Group AG, as SVP, Head-Organic Fine & Performance Chemicals from 2006 to 2007, SGS SA, as Executive Vice President-Industrial Services from 2010 to 2012, and Lonza AG, as Head-Strategic Projects from 2016 to 2018.
Dr. In-Albon received his Masters Business Admin degree in 1987 from the University of Fribourg and doctorate degree in 1983 from the University of Fribourg.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EVONEXT HOLDINGS SA 0.21% | 31/12/2024 | 15,381 ( 0.21% ) | 45 689 $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
Deccan Fine Chemicals (India) Pvt Ltd.
Deccan Fine Chemicals (India) Pvt Ltd. Chemicals: SpecialtyProcess Industries Manufactures agro and fine chemicals | Director/Board Member | 01/01/2019 |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | - |
Hans Kalbermatten Thermalbad AG | Chairman | 01/01/2021 |
Lonza Arena AG | Director/Board Member | 01/01/2020 |
| Companies | Position | End |
|---|---|---|
| EVONEXT HOLDINGS SA | Chairman | 18/04/2023 |
Escientia Switzerland AG | Chairman | 01/01/2021 |
Lonza AG
Lonza AG BiotechnologyHealth Technology Engages in developing, producing and selling pharmaceutical and chemical products | Corporate Officer/Principal | 01/01/2018 |
| SIEGFRIED HOLDING AG | Director/Board Member | 01/09/2012 |
| SGS SA | Corporate Officer/Principal | 01/01/2012 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Lonza Group AG
Lonza Group AG BiotechnologyHealth Technology Develops and manufactures, biologics, biopharmaceuticals, small molecules & health ingredients | Health Technology |
SGS SA
SGS SA Miscellaneous Commercial ServicesCommercial Services Provides testing, inspection and certification services | Commercial Services |
Siegfried Holding AG
Siegfried Holding AG Pharmaceuticals: MajorHealth Technology Develops and manufactures active pharmaceutical ingredients, dosage forms & biopharmaceutical substances | Health Technology |
Siegfried AG
Siegfried AG Chemicals: AgriculturalProcess Industries Manufactures chemical products | Process Industries |
University of Fribourg
University of Fribourg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolva Holding SA
Evolva Holding SA Food: Specialty/CandyConsumer Non-Durables Develops and sells flavors, fragrances and health ingredients | Consumer Non-Durables |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Lonza AG
Lonza AG BiotechnologyHealth Technology Engages in developing, producing and selling pharmaceutical and chemical products | Health Technology |
Hans Kalbermatten Thermalbad AG | |
Deccan Fine Chemicals (India) Pvt Ltd.
Deccan Fine Chemicals (India) Pvt Ltd. Chemicals: SpecialtyProcess Industries Manufactures agro and fine chemicals | Process Industries |
Escientia Switzerland AG | |
PolyPeptide Group AG
PolyPeptide Group AG BiotechnologyHealth Technology Manufactures polypeptide and custom peptide synthesis | Health Technology |
Lonza Arena AG |
Select your edition
All financial news and data tailored to specific country editions